Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

22

May 2019

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ZoBio the leading contract research organization in integrated fragmentbased drug discovery today announced significant progress made as part of their collaboration to identify therapeutic l...

22

May 2019

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck known as MSD outside the United States and Canada and Peloton Therapeutics Inc today announced that the companies have entered into a definitive agreement under which Merck through a subsidiary will acquire privately held Peloton a clinicalstage biopharmaceutical company

21

May 2019

Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology

Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in Oncology Foundation Alliance a USbased cancer research network sponsored by the National Cancer Institute

21

May 2019

Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study

Personalis Inc a leader in advanced genomics for cancer today announced that it has entered into a research agreement with FLX Bio Inc a biopharmaceutical company developing orallyavailable small molecule drugs targeting the immune drivers of cancer and inflammatory diseases

17

May 2019

RegeneRx Partner Receives Patent for New Ophthalmic Formulation of Thymosin Beta 4

RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration reported today that its US joint venture partner and Pan Asian licensee GtreeBNT has been granted a new US patent for a method of preventing or treating dry eye syndrome

press releasesRead more...

22

May 2019

Avalon GloboCare Partners with MIT to Develop Innovative AI-Enhanced Protein Design Technology in Cellular Therapy

Avalon GloboCare Corp a leading global developer of cellbased technologies and therapeutics today announced it has entered into a sponsored research and licensing agreement with Massachusetts Institute of Technology MIT to generate novel therapeutic targets for cellular therapy using artificial inte...

22

May 2019

Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse

Santhera Pharmaceuticals announces its collaboration with the Biozentrum of the University of Basel to advance gene therapy research for the treatment of LAMAdeficient congenital muscular dystrophy LAMA MD or MDCA

21

May 2019

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

SpringWorks Therapeutics a clinicalstage biopharmaceutical company focused on developing lifechanging medicines for patients with severe rare diseases and cancer today announced that the first patient has been dosed in the Phase DeFi DesmoidFibromatosis trial evaluating nirogacestat an oral selecti...

21

May 2019

BioXcel Therapeutics Achieved Targeted Exposures of BXCL501 Designed For Non-Invasive Acute Treatment of Agitation in Neuropsychiatric Diseases

BioXcel Therapeutics Inc today announced positive top line data from its Phase pharmacokinetic PK bioavailability and safety study of BXCL a proprietary sublingual thinfilm formulation of dexmedetomidine Dex for the acute treatment of agitation across multiple neuropsychiatric indications

17

May 2019

Strong line-up: Chemspec Europe 2019 gathers impressive array of industry experts under one roof

Preparations for the International Exhibition for Fine and Speciality Chemicalsare well under way From June the thedition of Chemspec Europe provides a powerful and wellknown industry platform to explore bespoke solutions new approaches and innovative substances as well as to discuss the latest m...

EventsRead more...

20 - 23

May 2019

21 - 23

May 2019

Neuroimmunology Drug Development Summary Summit

Hanson Wade
Hilton Paris La Defense

21 - 23

May 2019

Precision CRISPR Genome

Hanson Wade
Westin Boston Waterfront

23 - 23

May 2019

10th Annual Clinical Trials Summit 2019

Virtue Insight
Kohinoor Continental Hotel

Advertisements

MECO - 90 Years

TOP ARTICLES

  • 5

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel ex...

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION